These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 1973398)
21. In vitro studies on cetamolol, a new potent cardioselective beta-adrenoceptor blocking agent with intrinsic sympathomimetic activity. Grimes D; Stern M; Wojdan A; Cummings JR Can J Physiol Pharmacol; 1983 Oct; 61(10):1109-15. PubMed ID: 6139156 [TBL] [Abstract][Full Text] [Related]
22. [Atenolol, its cardioselective property for adrenergic beta-receptor blocking action and effect on the cardiac function (author's transl)]. Kanno M; Nakaya H; Hattori Y; Izumi T; Nishimura T; Sakai K; Abiko Y Nihon Yakurigaku Zasshi; 1980 Oct; 76(7):621-32. PubMed ID: 6111522 [TBL] [Abstract][Full Text] [Related]
23. Effects of celiprolol (REV 5320), a new cardioselective beta-adrenoceptor antagonist, on in vitro adenylate cyclase, alpha- and beta-adrenergic receptor binding and lipolysis. Van Inwegen RG; Khandwala A; Weinryb I; Pruss TP; Neiss E; Sutherland CA Arch Int Pharmacodyn Ther; 1984 Nov; 272(1):40-55. PubMed ID: 6151380 [TBL] [Abstract][Full Text] [Related]
24. Selectivity of the intrinsic sympathomimetic activity of the beta-adrenergic blocking drug bucindolol. Leff AR; Garrity ER; Munoz NM; Tallet J; Cavigelli M; Deitchman D; Rajfer SI J Cardiovasc Pharmacol; 1984; 6(5):859-66. PubMed ID: 6209492 [TBL] [Abstract][Full Text] [Related]
26. Celiprolol: agonist and antagonist effects at cardiac beta 1- and vascular beta 2-adrenoceptors determined under in vivo conditions in the rat. Alvarez-Guerra M; Alda O; Garay RP Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):689-98. PubMed ID: 9205952 [TBL] [Abstract][Full Text] [Related]
27. A highly selective beta1-adrenergic blocker with partial beta2-agonist activity derived from ferulic acid, an active component of Ligusticum wallichii Franch. Wu BN; Huang YC; Wu HM; Hong SJ; Chiang LC; Chen IJ J Cardiovasc Pharmacol; 1998 May; 31(5):750-7. PubMed ID: 9593075 [TBL] [Abstract][Full Text] [Related]
28. Comparative studies on beta-adrenolytic potencies of some new phenoxyaminopropanol derivatives and celiprolol. Mlynárová R; Racanská E Pharmazie; 1997 Mar; 52(3):234-7. PubMed ID: 9109170 [TBL] [Abstract][Full Text] [Related]
29. A beta-adrenoceptor blocking agent, befunolol as a partial agonist in isolated organs. Takayanagi I; Koike K Gen Pharmacol; 1985; 16(3):265-7. PubMed ID: 2862092 [TBL] [Abstract][Full Text] [Related]
30. Pharmacological analysis of the cardiac actions of xamoterol, a beta adrenoceptor antagonist with partial agonistic activity, in guinea pig heart: evidence for involvement of adenylate cyclase system in its cardiac stimulant actions. Hattori Y; Sakuma I; Nakao Y; Kanno M J Pharmacol Exp Ther; 1987 Sep; 242(3):1077-85. PubMed ID: 2888870 [TBL] [Abstract][Full Text] [Related]
31. Analysis of hypotensive mechanisms of pindolol, a beta-adrenoceptor blocking drugs in rats. Ozawa H; Matsubara T; Chen CS Jpn J Pharmacol; 1977 Apr; 27(2):295-302. PubMed ID: 18631 [TBL] [Abstract][Full Text] [Related]
32. Intrinsic beta-sympathomimetic activity of dilevalol, R, R-isomer of labetalol. Matsunaga K; Nakamura K; Ueda M J Pharmacobiodyn; 1985 Sep; 8(9):785-7. PubMed ID: 2868089 [TBL] [Abstract][Full Text] [Related]
33. [Pharmacological studies of celiprolol: III. Effects of celiprolol on the cardiovascular system and renal function, and its antiarrhythmic effects]. Ochi S; Kimura Y; Matsuzaki T; Hayashi S; Motonaga A; Tanaka M; Fukui H; Yamazaki A; Matsumura K; Miura A Nihon Yakurigaku Zasshi; 1990 Apr; 95(4):209-27. PubMed ID: 1973400 [TBL] [Abstract][Full Text] [Related]
34. Vanillylamide-based propanolamine derivative displays alpha/beta-adrenoceptor blocking and vasodilating properties. Yeh JL; Wu JR; Chiu CC; Chen YW; Lo YC; Lin YT; Cheng CJ; Chen IJ J Cardiovasc Pharmacol; 2002 Jun; 39(6):803-13. PubMed ID: 12021574 [TBL] [Abstract][Full Text] [Related]
35. In vitro studies on the pharmacological properties of diacetolol, the major metabolite of acebutolol in man. Borchard U; Hafner D; Hirth C Arch Int Pharmacodyn Ther; 1985 Jan; 273(1):4-17. PubMed ID: 2860878 [TBL] [Abstract][Full Text] [Related]